# A Dose-escalation Study of LPM3480392 in Chinese Healthy Subjects

> **NCT05862974** · PHASE1 · COMPLETED · sponsor: **Luye Pharma Group Ltd.** · enrollment: 80 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** LPM3480392
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05862974
- **Lead sponsor:** Luye Pharma Group Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-25
- **Primary completion:** 2021-11-02
- **Final completion:** 2021-11-02
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2023-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05862974

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05862974, "A Dose-escalation Study of LPM3480392 in Chinese Healthy Subjects". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05862974. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*